Page last updated: 2024-08-20

pregnenolone and Premenstrual Dysphoric Disorder

pregnenolone has been researched along with Premenstrual Dysphoric Disorder in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cintron, D; Khine, KK; Koziol, DE; Martinez, PE; Morrow, AL; Nieman, LK; Rubinow, DR; Schiller, CE; Schmidt, PJ; Thompson, KD	1

Trials

1 trial(s) available for pregnenolone and Premenstrual Dysphoric Disorder

Article	Year
5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2016, Volume: 41, Issue:4 Topics: 5-alpha Reductase Inhibitors; Adult; Androsterone; Cholestenone 5 alpha-Reductase; Double-Blind Method; Dutasteride; Female; Humans; Luteal Phase; Middle Aged; Pregnanolone; Pregnenolone; Premenstrual Dysphoric Disorder; Severity of Illness Index; Single-Blind Method	2016

Article

Year

5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2016, Volume: 41, Issue:4

Topics: 5-alpha Reductase Inhibitors; Adult; Androsterone; Cholestenone 5 alpha-Reductase; Double-Blind Method; Dutasteride; Female; Humans; Luteal Phase; Middle Aged; Pregnanolone; Pregnenolone; Premenstrual Dysphoric Disorder; Severity of Illness Index; Single-Blind Method

2016